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Although human metapneumovirus (hMPV) is primarily known as a causative agent of respiratory tract infections in
children, the virus also can cause respiratory infections in adults. hMPV infections tend to be mild and are self-
limiting, but the infections can be severe in the elderly and immunocompromised patients. Because hMPV infection
is quite common, it should be considered in every patient with respiratory failure in the intensive care unit (ICU).
We describe three adult patients, including a young pregnant woman, with hMPV infection who required
admission to our ICU. Two of them developed respiratory failure with indication for mechanical ventilation.
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Human metapneumovirus (hMPV) was first isolated in
the Netherlands in 2001 and was classified as the first
human member of the Metapneumovirus genus in the
subfamily Pneumovirinae of the family Paramyxoviridae
belonging to the order Mononegavirales. Serologic stud-
ies of antibodies against hMPV indicate that the virus is
not new and circulated in humans for at least 50 years
before 2001. hMPV is genetically most similar to the
Pneumoviridae family (a Paramyxoviridae subfamily), of
which respiratory syncytial virus (RSV) is a prominent
member. It is an enveloped, negative single-strand RNA
virus. Phylogenetic analysis identified two subgroups of
hMPV, subgroup A and B, and two clades within each of
these subgroups [1]. Both subtypes may co-circulate
simultaneously, but during an epidemic one subtype
usually dominates. The virus was named human metap-
neumovirus because of its genetic similarity to the avian
pneumovirus [2].
The virus is prevalent in all age groups, with peak inci-
dence in pediatric and elderly patients. It is the second
most common cause of lower respiratory tract infection
(LRTI) in young children, after RSV [3]. Several series of
children with RTI have been published, and they report* Correspondence: lvlelyveld@diakhuis.nl
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in any medium, provided the original work is phighest rates among children younger than age 1 year
(4–15%) [4-9]. Serologic studies show that virtually all
children have been exposed to the virus by age 5 years
[10,11]. Reinfections are common and appear to be a
mild but can be severe. Although most reports concern
children, hMPV also is an important cause of RTI in
adults [12,13]. hMPV infection rates in adults appear to
be lower than in children and infection often is asymp-
tomatic, but in the elderly, the immunocompromised,
and patients with underlying pulmonary and/or cardiac
disease hMPV can cause severe RTI [14-18].
hMPV seems to be distributed worldwide and has a
seasonal distribution comparable to that of the influenza
virus; it tends to strike in the late winter and early spring
[7]. Transmission is by direct or close contact with con-
taminated secretions, which may involve saliva, droplets,
or large particle aerosols. The incubation period is ap-
proximately 3 to 6 days [19]. The signs and symptoms of
hMPV infection are indistinguishable from those caused
by RSV. Like RSV, hMPV has a tropism for the respira-
tory epithelium. The patient may be asymptomatic or
symptoms may range from mild upper RTI symptoms to
severe pneumonia. Most patients present with cough,
dyspnea, and fever. Sputum production, wheezing, sore
throat, pneumonia, bronchi(oli)tis, conjunctivitis, and
otitis media are other reported symptoms [20].
A general respiratory virus culture obtained by nasal
wash or nasopharyngeal swab should be performed in
patients with clinical symptoms of LRTI. Virus isolation,Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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slowly and inefficient in cultures. Detection techniques
that have been developed include identification by
reverse transcriptase-polymerase chain reaction (RT-PCR)
assay, enzyme-linked immunosorbent assay (ELISA), and
the rapid culture technique known as shell vial amplifi-
cation. The first is the most sensitive method for diagno-
sis of hMPV infection.
Treatment of hMPV infection is supportive. Ribavirin
and polyclonal intravenous immune globulin has been
shown to be effective in vitro and in mice but has not
been tested sufficiently in humans yet [21,22]. Hospita-
lized patients with hMPV infection should be cared for
in a separate room. There has been no vaccine available
until now.
Although hMPV usually causes mild RTI, it can cause
severe disease in vulnerable patients.
As far as we know, there are not many publications
about hMPV in the adult intensive care unit (ICU). We
report three cases of adult patients with hMPV infection,
who required admission to our ICU. The patients were
not admitted during the same period.Case 1
A 38-year-old man was admitted to the pulmonology
ward because of fever, progressive dyspnea, and a pro-
ductive cough lasting several days. He was known to
have chronic obstructive pulmonary disease (COPD),
diabetes mellitus, and schizophrenia, for which salbuta-
mol, fluticasone inhalations, metformin, and clozapine
was prescribed.
At physical examination, a slightly dyspneic, anxious,
obese patient was seen, with a blood pressure of 140/
79 mmHg, heart rate 152 beats per minute, temperature
of 40°C, and oxygen saturation was 91% without supple-
mental oxygen. Further physical examination was not
remarkable; lung auscultation revealed normal breath
sounds.
Laboratory examination showed: CRP 86 mg/l
(<10 mg/l), ESR 87 mm/h (1–7 mm/h), Hb 9.7 mmol/l
(6.9- 10.0 mmol/l), Hct 0.46 l/l (0.38-0.49 l/l), MCV 85 fl
(82–98 fl), thrombocytes 230 x10E9/l (150–350 x10E9/l),
leucocytes 12.5 x10E9/l (4.0-10.0 x10E9/l), arterial blood
analysis: pH 7.43 (7.35-7.45), pCO2 4.9 kPa (4.7- 6.4 kPa),
pO2 6.6 kPa (10.0-13.3 kPa), HCO3 23.9 mmol/l (22.0-
29.0 mmol/l), base excess 0.0 mmol/l (−3.0-3.0 mmol/l),
oxygen saturation 99% (95-98%), lactate 1.5 mmol/l
(0.5-2.2 mmol/l), amylase 68 U/l (<100 U/l), creatinine
kinase 371 U/l (<175 U/l), and glucose 11,0 mmol/l (3.0-
7.7 mmol/l). Kidney function and electrolytes were within
the normal range and, except for a gamma-GT of 171 U/l
(<50 U/l), liver enzymes were normal. Chest x-ray (CXR)
showed a consolidation in the left lung.Cultures of blood and sputum, L. pneumophilia and
S. pneumoniae antigen testing in urine, testing for
tuberculosis (auramine staining and enzyme-linked
immunosorbent spot (ELISPOT) assay) and human
immunodeficiency virus, serologic test for Legionella,
Mycoplasma, and Chlamydia infection all were negative.
Viral cultures of the throat showed a positive PCR for
hMPV (see Appendix, Ct 32 in the throat), whereas
other viruses (adenovirus, influenza A and B, parainflu-
enza 1, 2, and 3, rhinovirus, and RSV A and B) tested
negative.
Initially he was treated with ceftriaxone, steroids, and
bronchodilators (anticholinergics and beta-adrenergic re-
ceptor agonist), but because of progressive dyspnea the
antibiotic regime was switched the next day to penicillin
combined with erythromycin. Nevertheless, he devel-
oped respiratory failure and was admitted to our ICU
for mechanical ventilation. According to our ICU proto-
col, the penicillin was replaced by cefotaxime, as part of
the selective digestive decontamination strategy [23,24].
After 5 days, mechanical ventilation was discontinued,
and 4 days later he was discharged from the hospital in
good clinical condition.Case 2
A 73-year-old man presented to the emergency room
(ER) with progressive dyspnea and a productive cough
lasting 1 day, without fever. He also complained of nau-
sea and anorexia.
He had known COPD Gold stage IV, for which he was
being treated with tiotropium, salmeterol, salbutamol,
fluticasone, and corticosteroids maintenance therapy
(prednisone 5 mg once daily).
Physical examination showed an acutely ill cachectic
man, who was tachypneic and dyspneic. He was not able
to speak full sentences. Blood pressure was 189/
94 mmHg, heart rate 102 beats per minute, temperature
was T 36.3°C, and the saturation measured was 97% with
6 liters/minute supplemental oxygen. Auscultation of
the lungs revealed bilateral wheezing.
Laboratory results showed: CRP 28 mg/l (<10 mg/l),
ESR 32 mm/h (1–7 mm/h), Hb 9.3 mmol/l (6.9-
10.0 mmol/l), Hct 0.45 l/l (0.38-0.49 l/l), MCV 94 fl
(82–98 fl), thrombocytes 194 x10E9/l (150–350 x10E9/l),
leucocytes 7.4 x10E9/l (4.0-10.0 x10E9/l), arterial blood
analysis: pH 7.33 (7.35-7.45), pCO2 7.7 kPa (4.7-6.4 kPa),
pO2 16.6 kPa (10.0-13.3 kPa), HCO3 29.6 mmol/l (22.0-
29.0 mmol/l), base excess 2.1 mmol/l (−3.0-3.0 mmol/l),
oxygen saturation 99% (95-98%), lactate 1.5 mmol/l
(0.5-2.2 mmol/l), and glucose 7.0 mmol/l (3.0-7.7 mmol/l).
Kidney function, electrolytes, and liver enzymes all were in
the normal range. CXR showed severe emphysema but no
other significant abnormalities.
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ation with a single dose of gentamicin) was started after
cultures had been taken, and dexamethasone 10 mg
intravenous once daily combined with bronchodilators
were started. He was transferred to our ICU for nonin-
vasive positive pressure ventilation.
Serologic testing for Chlamydia, Mycoplasma, and
Legionella and also testing (both serology and PCR)
for Coxiella burnetti were negative. Sputum culture
revealed Moraxella catarrhalis and S. aureus in limited
numbers. PCR of both nose and throat swabs were
positive for hMPV (cycle threshold (Ct) 23 in the nose
and Ct 26 in the throat). Other viruses (adenovirus,
influenza A and B, parainfluenza 1, 2, and 3, rhino-
virus, and RSV A and B) tested negative.
Despite this therapy, further deterioration developed,
and in view of the end-stage COPD and his advance dir-
ective, treatment was restricted and he deceased soon.
Case 3
A 24-year-old woman, with no previous medical history,
was admitted to the obstetrics/gynecology ward during
the 30th week of an, until then, uncomplicated pregnancy
(G1P0). She was suffering from fever and continuous
pain in the right flank related to breaths since 3 days.
Urine-analysis showed leukocyturia (242/μl, with 39 ery-
throcytes/μl) and bacteriuria. After cultures of urine,
blood, and cervix were taken, amoxicillin/clavulanate was
started for a urinary tract infection. Because of progres-
sive tachypnea and the suspicion of progressive sepsis,
antibiotic therapy was switched to a third-generation
cephalosporin and subsequently to meropenem the next
day because of further clinical deterioration. CXR on ad-
mission was normal. Despite therapy, respiratory insuffi-
ciency developed and she was transferred to our ICU.
On admission to the ICU, she was febrile (body
temperature 39°C), tachycardic (heart rate 132 beats/
min), hypotensive (blood pressure 82/50 mmHg), and
tachypneic (respiratory rate 40 breaths/min). Saturation
without supplemental oxygen was 96%. Arterial blood
gas analysis showed (normal reference ranges for preg-
nant woman in third trimester of pregnancy between
brackets [25]): pH 7.41 (7.39-7.53), PaCO2 4.4 kPa (3.3-
4.4 kPa), PaO2 11.7 kPa (12.2-14.2 kPa), HCO3
20.6 mmol/l (16–22 mmol/l), and saturation 97% (95-
98%). Further laboratory examination showed: Hb
4.8 mmol/l (5.9-9.3 mmol/l), Ht 0.23 l/l (0.28-0.40 l/l),
MVC 88 (81–99), leucocytes 13.8/nl (5.9-16.9/nl) with
12.7 neutrophils/nl (3.9-13.1 neutrophils/nl), platelets
179/nl (146-429/nl), CRP 231 mg/l (0.4-8.1 mg/l). Another
CXR again showed no abnormalities. Cardiotocography
was performed repeatedly and showed no abnormalities.
Ultrasound of the kidneys showed dilatation of the pye-
lum, particularly in the right kidney with hypoechoicareas, which could be due to pyelonephritis. Drainage was
performed immediately and clear urine was released.
However, symptoms persisted with progressive oxygen de-
mand (40% oxygen by Venturi mask), and a computed
angiography was performed. Pulmonary embolism was
ruled out, but to our surprise bilateral alveolar consolida-
tions were seen, not visible on both CXRs performed
earlier.
Both L. pneumophilia and S. pneumoniae antigen test-
ing in urine were negative. E. coli, susceptible to amoxi-
cillin, was cultured in the urine. A general respiratory
virus culture was obtained by a nasopharyngeal swab,
and PCR was positive for hMPV (Ct 24 in the throat
and Ct 33 in the nose). Other viruses (adenovirus, influ-
enza A and B, parainfluenza 1, 2, and 3, rhinovirus, and
RSV A and B) all tested negative. Fortunately, no mech-
anical ventilation was necessary. She was treated with
amoxicillin and high-dose oxygen, and she could be
transferred to the obstetric ward after 3 days. A healthy
girl was born 6 weeks later.
Discussion
We report three adult patients with severe hMPV infec-
tion who required treatment in the ICU. Two of them
developed respiratory failure with indication for mech-
anical ventilation and one of these eventually died, also
as a consequence of his underlying pulmonary disease.
Although the relevance of viral detection is always ques-
tionable, because since viral detection does not system-
atically mean viral infection and the virus could be a
bystander rather than a true pathogen, we think that
these patients really suffered from hMPV infection,
because there were no indications for another causative
organism.
It is generally known that hMPV infection is common
among children, but it seems that hMPV also plays a sig-
nificant role in adult patients. The elderly and immuno-
compromised patients, including pregnant women, are
especially at risk, and hMPV can cause severe RTI in
these patients [26-29]. Previously, most of the infections
were attributed to influenza, but both RSV and hMPV
are now considered to be at least equally important.
RSV infections also are not solely restricted to pediatric
and high-risk adult populations. Healthy adults are
infected repeatedly throughout their lives with RSV and
typically have symptoms restricted to the upper respira-
tory tract. Studies in the United States have shown that
the annual incidence of RSV infection was nearly twice
that of influenza A and that annually 3–7% of the
healthy elderly persons and 4–10% of high-risk patients
developed a RSV infection. RSV and influenza A infec-
tions resulted in comparable lengths of stay, need for in-
tensive care monitoring, and mortality (8% and 7%,
respectively) [30,31]. In data compiled by the Centers for
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in as many as 199,000 deaths per year globally [32]. In
both elderly and immunosuppressed patients, RSV is an
often unrecognized cause of LRTI [33-35]. We believe
that, due to the similarities between RSV and hMPV, the
latter might be of the same importance as RSV. Besides
hMPV and RSV, other viruses can cause RTI, such as
adenovirus, influenza, parainfluenza and, although less
frequently, enterovirus. Distinguishing the viruses clinic-
ally is difficult; diagnostic testing includes culture, RT-
PCR, and serology.
We analyzed all PCR tests for respiratory viruses from
the past 19 months in our hospital. A total of 487
patients were tested for hMPV because of symptoms of
RTI. More than half of them (283 = 58%) concerned
adult patients, and 14 (4.94%) patients were positive. In
the remaining 204 pediatric patients, 12 (5.88%) tested
positive.
These three cases occurred in the winter: the first case
in January 2010, the second in March 2011, and the last
in January 2011. In 2011, at total of 277 persons were
tested for hMPV. More than 70% (198/277 = 71.5%) con-
cerned adult patients and four of them (4%) tested posi-
tive. During the period from January to March 2011, 112
patients were tested, including 77 adults; 3 of them
(3.9%) tested positive. In this series, the incidence of
hMPV is lower in the children group (approximately 2%
versus approximately 4%), but this can be caused by a
selection bias, because only samples from children with
a negative RSV antigen test were analyzed further by
PCR testing. These incidences are lower than the inci-
dence reported by Li and colleagues [13]. We think that
the incidences that we found are a considerable under-
estimation. The real incidence of hMPV infections is dif-
ficult to measure or estimate; first, because a great part
of the patients with respiratory symptoms presenting to
our hospital are not tested for viral infections. Second, a
great part of the hMPV infections is asymptomatic or
mild, and these patients do not present to the hospital at
all, so the asymptomatic and less severe cases also are
missed.
The first patient was known with diabetes mellitus and
used inhalation steroids. Therefore, he could be consid-
ered immunocompromised and the underlying pulmon-
ary disease made him vulnerable for progressive
respiratory failure due to a viral infection. Because no
microorganism was cultured, we considered a viral cause
and PCR for respiratory viruses was performed.
Although sputum cultures can be negative, even in the
case of true bacterial pneumonia, and the urine tests for
Legionella pneumophilia detects only antigens of
serotype 1 and also has no 100% sensitivity, we think
that the most plausible diagnosis in this case is a severe
hMPV infection.The second patient was known with serious COPD
and used both inhalation steroids and oral corticoster-
oids maintenance therapy; therefore, he also could be
considered immunocompromised. The hMPV infection
in combination with his explicit wishes not to use inva-
sive mechanical ventilation, finally resulted in his death,
although it cannot be ruled out that a bacterial infection
with the cultured Moraxella catarrhalis and S. aureus
might have played a role.
Although presentation with classic symptoms of fever
and dyspnea, the diagnostic process was complicated in
the last patient. Because she had no respiratory symp-
toms and pulmonary auscultation and CXR were not re-
markable, we focused on the leukocyturia and bacteriuria
in combination with the flank pain and bilateral hydro-
nephrosis. It was not before we got the viral diagnostic
test results and saw the consolidations on CT images
that we reconsidered pneumonia as the most probable
diagnosis. Retrospectively, we can say that the bacteriuria
and pyelumdilatation has misled us, leading to unneces-
sary drainage of both kidneys. Bilateral hydronephrosis
can occur during pregnancy due to enlargement of the
uterus. Sometimes it can be difficult to distinguish clinic-
ally between pneumonia and urosepsis as the cause of
the respiratory deterioration. Maybe the flank pain was
caused by the pneumonia.
We think the hMPV was the causative pathogen, but a
bacterial pneumonia could not completely be ruled out,
because the patient was treated with broad-spectrum
antibiotic without sampling of the lower respiratory
tract. An acute lung injury due to urinary sepsis could
be another possible explanation.
It is generally known that the immunocompromised
patient is susceptible for hMPV infection. Even though
pregnant women can be considered mildly immunodefi-
cient, severe infection in pregnant women has not been,
as far as we know, reported previously. The unborn child
was unaffected by the virus and was born healthy.
Conclusions
hMPV can cause serious RTI in vulnerable adult
patients. Because hMPV infection is quite common, it
should be considered in every patient with respiratory
failure in the ICU.
Appendix
 RT- PCR
After addition of 10 μl of internal control (Phocine
Distemper Virus), viral RNA or DNA was isolated
from 190 μl of nasopharyngeal swab supernatant by
use of the Total Nucleic Acid High Performance Kit
(protocol Total NA HP200) on the MagNA Pure LC
(Roche Diagnostics). cDNA synthesis and
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(TaqMan(R) Fast Virus 1-step Master Mix
(#4444436, Life Technologies/Applied Biosystems)
and 10 μl eluate on an ABI 7500 SDS. Specific
primers and probes were used for the detection of
HMPV [16], RSV types A and B, rhinovirus, PIV-3
[17], PIV1-2, adenovirus [18], and influenza A and B
[19]. Amplified products were detected using
pathogen-specific FAM-, VIC-, or CY5-labeled
Taq-Man probes. Positive and negative controls
were included in each run.Competing interests
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